An in silico drug treatment model to assess the robustness of regional age-based dosing regimens for artemisinin-based combination therapies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2875
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
An in silico drug treatment model to assess the robustness of regional age-based dosing regimens for artemisinin-based combination therapies ; volume:11 ; number:1 ; day:15 ; month:10 ; year:2012 ; pages:1 ; date:10.2012
Malaria journal ; 11, Heft 1 (15.10.2012), 1, 10.2012
- Creator
-
Staehli Hodel, Eva Maria
- Contributor
-
Kay, Katherine
Hayes, Daniel
Terlouw, Anja
Hastings, Ian
SpringerLink (Online service)
- DOI
-
10.1186/1475-2875-11-S1-P91
- URN
-
urn:nbn:de:1111-2016080638014
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Staehli Hodel, Eva Maria
- Kay, Katherine
- Hayes, Daniel
- Terlouw, Anja
- Hastings, Ian
- SpringerLink (Online service)
Other Objects (12)
From chloroquine to artemisinin-based combination therapy: the Sudanese experience
Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia
Adaptive dosing of anticancer drugs in neonates: facilitating evidence-based dosing regimens
Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies
Triple artemisinin-based combination therapy (TACT): advancing malaria control and eradication efforts
Novel artemisinin-based antiviral, antimalarial and anticancer hybrid compounds via click chemistry
Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up
Preference for Artemisinin–based combination therapy among healthcare providers, Lokoja, North-Central Nigeria
Adherence to prescribed artemisinin-based combination therapy in Garissa and Bunyala districts, Kenya
Willingness and ability to pay for artemisinin-based combination therapy in rural Tanzania
From chloroquine to artemisinin-based combination therapy: the Sudanese experience
Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia
Adaptive dosing of anticancer drugs in neonates: facilitating evidence-based dosing regimens
Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies
Triple artemisinin-based combination therapy (TACT): advancing malaria control and eradication efforts
Novel artemisinin-based antiviral, antimalarial and anticancer hybrid compounds via click chemistry
Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up
Preference for Artemisinin–based combination therapy among healthcare providers, Lokoja, North-Central Nigeria
Adherence to prescribed artemisinin-based combination therapy in Garissa and Bunyala districts, Kenya
Willingness and ability to pay for artemisinin-based combination therapy in rural Tanzania
From chloroquine to artemisinin-based combination therapy: the Sudanese experience
Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia
Adaptive dosing of anticancer drugs in neonates: facilitating evidence-based dosing regimens
Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies
Triple artemisinin-based combination therapy (TACT): advancing malaria control and eradication efforts
Novel artemisinin-based antiviral, antimalarial and anticancer hybrid compounds via click chemistry
Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up
Preference for Artemisinin–based combination therapy among healthcare providers, Lokoja, North-Central Nigeria
Adherence to prescribed artemisinin-based combination therapy in Garissa and Bunyala districts, Kenya